Pharma: The dubious billion-dollar business with women in menopause
Investors and pharmaceutical companies are investing billions in products for women in menopause. Yet there is a lack of effective therapies. One German provider is benefiting.
Munich. For decades, investors and pharmaceutical companies showed little interest in the complaints of women going through menopause, despite it affecting more than half of the global population at some point in their lives. Suddenly, hot flashes have become a hot business. Financial investors and private backers are pouring billions into the sale of products for women going through menopause.
Telemedicine providers are promoting hormone therapies. Companies are offering programs for women in menopause as a new "employee benefit." An era has passed where women silently endured their complaints, and menopause was largely out of public view. Influencers and celebrities such as Oprah Winfrey and Serena Williams promote menopause products, with the hashtag #menopause garnering billions of views on TikTok.
The long-overdue momentum is finally here. However, few women are receiving effective help. Is the investment boom addressing the actual problem?
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
